6th Annual Comprehensive Neurotoxin Course
In-Person Event
Nov 10, 2017
Cleveland, Ohio, USA
OVERVIEW
6th Annual Comprehensive Neurotoxin Course is organized by Cleveland Clinic Foundation Center for Continuing Education and would be held on Nov 10, 2017 at G Building - Cleveland Clinic, Cleveland, Ohio, United States of America.
The target audience for this medical event for neurologists, physiatrists, residents, fellows and nurse practitioners. This CME Conference has been approved with a maximum of 7.0 AMA PRA Category 1 Credits.
Conference Objectives are :
• Describe the fundamental pharmacology of botulinum toxin, its history, mechanisms of action, duration and onset of action, potential side effects, contraindications, and clinical indications.
• List the four toxin types available in North America and summarize their differences and similarities in clinical response, dosing, side effects, preparation, and administration.
• Review the different therapeutic uses of botulinum toxins in neurological disorders, both FDA-approved indications (eg, cervical dystonia, blepharospasms, headache, upper limb spasticity) and off-label uses (eg, limb spasticity and dystonia, hemifacial spasms, oromandibular dystonia, spasmodic dysphonia, sialorrhea, tics, tremor).
• Describe the proper administration of all types of botulinum toxins including anatomic localization, target and muscle selection, use of electromyographic and ultrasound guidance, and injection techniques. Illustrate the proper and ethical process of consent, preauthorization, billing, and coding for botulinum toxin use.
Additional details will be posted as soon as they are available.
The target audience for this medical event for neurologists, physiatrists, residents, fellows and nurse practitioners. This CME Conference has been approved with a maximum of 7.0 AMA PRA Category 1 Credits.
Conference Objectives are :
• Describe the fundamental pharmacology of botulinum toxin, its history, mechanisms of action, duration and onset of action, potential side effects, contraindications, and clinical indications.
• List the four toxin types available in North America and summarize their differences and similarities in clinical response, dosing, side effects, preparation, and administration.
• Review the different therapeutic uses of botulinum toxins in neurological disorders, both FDA-approved indications (eg, cervical dystonia, blepharospasms, headache, upper limb spasticity) and off-label uses (eg, limb spasticity and dystonia, hemifacial spasms, oromandibular dystonia, spasmodic dysphonia, sialorrhea, tics, tremor).
• Describe the proper administration of all types of botulinum toxins including anatomic localization, target and muscle selection, use of electromyographic and ultrasound guidance, and injection techniques. Illustrate the proper and ethical process of consent, preauthorization, billing, and coding for botulinum toxin use.
Additional details will be posted as soon as they are available.
KEY DATES
10 Nov, 2017
Event Start Date
10 Nov, 2017
Event End Date
SPECIALITIES
NeurologySUGGESTED HOTELS
CONFERENCE VENUE
G Building-Cleveland ClinicRELATED CONFERENCES & LIVE WEBINARS
Quick Links